What You May Have Missed in 2024 - Part 2

2025-10-20

Annals On Call Podcast

0:00

13:52

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."

Fler avsnitt från "Annals On Call Podcast"

Palliative Care: A Family Perspective
2025-11-17
19:37
Dr. Centor discusses a family perspective on palliative care with Ms. Monica Wright, the author of an On Being a Patient essay.
What You May Have Missed in 2024: Part 3
2025-11-03
15:33
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
Missa inte ett avsnitt av “Annals On Call Podcast” och prenumerera på det i GetPodcast-appen.
What You May Have Missed in 2024 - Part 2
2025-10-20
13:52
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
High-Concentration Cannabinoids: Are They Safe?
2025-10-06
29:05
Dr. Centor discusses currently available evidence about high-concentration cannabis products and mental health outcomes with Drs. Paula Riggs and Jonathan Samet.
What You May Have Missed in 2024: Part 1
2025-09-15
20:13
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
Fibrillation - When Ablation is the Way to Go
2025-09-01
22:36
Dr. Centor discusses the role of ablation in the management of patients with atrial fibrillation with Dr. Peter Zimetbaum.
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
2025-08-18
29:55
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide
2025-08-04
21:11
Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide.
Diagnosing Primary Aldosteronism
2025-07-14
23:56
Dr. Centor discusses the diagnosis of primary aldosteronism with Dr. Jordana Cohen.
Virtual Urgent Care: Artificial Intelligence Versus Physicians
2025-06-30
19:07
Dr. Centor discusses artificial intelligence-assisted urgent care with Dr. Zehavi Kugler.

Fler avsnitt

Kom åt alla poddsändningar i gratisappen GetPodcast.

Prenumerera på dina favoritpoddar, lyssna på avsnitt offline och få spännande rekommendationer.

What You May Have Missed in 2024 - Part 2

Annals On Call Podcast

Fler avsnitt från "Annals On Call Podcast"

Palliative Care: A Family Perspective

What You May Have Missed in 2024: Part 3

What You May Have Missed in 2024 - Part 2

High-Concentration Cannabinoids: Are They Safe?

What You May Have Missed in 2024: Part 1

Fibrillation - When Ablation is the Way to Go

Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes

Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide

Diagnosing Primary Aldosteronism

Virtual Urgent Care: Artificial Intelligence Versus Physicians